Magnesium ‘should be used more often’ to prevent cerebral palsy

At the annual meeting of the Perinatal Society of Australia & New Zealand in Sydney this week, obstetricians and neonatologists were due to discuss their concerns that unnecessary cerebral palsy cases are occurring because hospitals have failed to implement NHMRC guidelines from 2010. 

The guidelines recommend that magnesium sulphate should be used for neuroprotection in women at imminent risk of early preterm (22–30 weeks’ gestation) birth.